DVT Death statistics take on a sharper edge in 2026, with recorded deaths falling and rising unevenly by setting and patient risk level. That swing is exactly what makes the trend worth checking closely, because the pattern does not follow what many people assume about prevention. Let’s look at the numbers behind Dvt Death and what they suggest when you separate the categories.
Key Takeaways
- Anticoagulant therapy reduces DVT mortality by 60%
- In US men aged 50-59, DVT incidence is 48 per 100,000
- In the United States, between 60,000 and 100,000 people die annually from venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE)
- In the US, DVT/PE mortality has declined 38% from 1999-2006 due to awareness
- Obesity increases DVT death risk by 2.5-fold
DVT deaths remain a serious concern, making prevention and early treatment more crucial than ever.
Related reading
01 · Category
Clinical Outcomes20 stats
01
Anticoagulant therapy reduces DVT mortality by 60%
02
Thrombolysis in massive PE lowers mortality from 65% to 25%
03
IVC filter use prevents fatal PE in 50% of high-risk DVT cases
04
LMWH prophylaxis cuts hospital VTE deaths by 40%
05
Early ambulation post-surgery reduces DVT death risk 70%
06
DOACs lower recurrent VTE mortality by 50% vs warfarin
07
Compression stockings reduce post-thrombotic DVT mortality 25%
08
Aspirin prophylaxis prevents 30% of fatal DVT in ortho surgery
09
Statins reduce DVT recurrence mortality by 20%
10
Bariatric surgery lowers obesity-related DVT deaths 40%
11
Heparin reduces PE mortality by 50% in DVT treatment
12
Catheter-directed thrombolysis mortality <2% vs systemic 10%
13
Prophylaxis in medical patients cuts deaths 50-70%
14
Fondaparinux lowers risk 50% vs enoxaparin
15
Mechanical prophylaxis alone 30% less effective than pharma
16
Edoxaban reduces bleeding mortality 50% in DVT
17
Extended prophylaxis prevents 80% recurrences
18
PEEP ventilation in PE lowers mortality 20%
19
Multidisciplinary VTE team reduces hospital deaths 25%
20
Surveillance ultrasound detects 90% DVT, prevents 40% deaths
Interpretation
Clinical Outcomes Interpretation
While each weapon in our arsenal against clot-related death has its own success rate, from dramatically slashing mortality with anticoagulants to the humble but mighty compression stocking, the clear, collective message is that doing something—whether it's a shot, a pill, or simply getting a patient walking—beats doing nothing by a country mile.
02 · Category
Demographics19 stats
01
In US men aged 50-59, DVT incidence is 48 per 100,000
02
Women over 80 have highest DVT/PE mortality at 200 per 100,000
03
African Americans have 30% higher VTE incidence than Caucasians
04
US annual DVT deaths peak in winter months at 15% higher rate
05
Males have 25% higher fatal PE rate than females post-50
06
Nursing home residents DVT mortality 5 times general population
07
Children <18 have 1% of adult DVT deaths but 20% higher fatality
08
In US, 40% of DVT deaths in patients under 50 years old
09
Hispanic population VTE mortality 15% lower than non-Hispanic whites
10
Urban vs rural DVT death rate 10% higher in rural areas
11
US females 18-39 DVT rate 13 per 100,000, higher in pregnancy
12
Males 70+ have 120 per 100,000 DVT incidence
13
Asian Americans lowest VTE mortality at 50% of whites
14
Southern US states higher DVT deaths by 15%
15
Veterans have 2x DVT mortality rate
16
Low-income groups 25% higher DVT fatality
17
Pediatric DVT mostly provoked, 5-10% mortality
18
Postpartum week 1-6 DVT deaths peak at 40%
19
Industrial workers DVT risk 1.5x office workers
Interpretation
Demographics Interpretation
These statistics paint a stark portrait where your risk of dying from a blood clot is not just a medical matter, but a story written by your age, your race, your job, your address, your gender, and even the season you find yourself in.
03 · Category
Epidemiology30 stats
01
In the United States, between 60,000 and 100,000 people die annually from venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE)
02
Globally, DVT contributes to approximately 10% of hospital deaths
03
In Europe, over 500,000 deaths occur yearly from preventable VTE related to DVT
04
DVT/PE incidence in the US is about 900,000 cases per year, with a portion leading to death
05
Post-surgical DVT risk leads to 20-50% of hospital-acquired VTE deaths
06
In hospitalized patients, DVT-related mortality is 15-20% within 3 months
07
Cancer patients have a 4-7 fold increased risk of fatal PE from DVT
08
Pregnancy-associated DVT deaths account for 9.3% of maternal mortality in developed countries
09
In the UK, VTE causes around 25,000 deaths per year
10
Australia reports 5,000-10,000 DVT/PE deaths annually
11
In France, DVT-related deaths are estimated at 18,000 per year
12
Germany sees about 40,000 VTE deaths yearly, mostly from DVT complications
13
Japan has a DVT mortality rate of 0.1-0.2 per 1,000 hospital admissions
14
In India, DVT underdiagnosis leads to 100,000+ potential deaths yearly
15
Brazil estimates 50,000 VTE deaths per year from DVT/PE
16
South Africa reports high DVT mortality in HIV patients at 20-30%
17
In the US, annual DVT incidence is 1-2 per 1,000 adults, with 10% fatal PE
18
Worldwide, DVT causes 1 in 4 VTE deaths in surgical patients
19
ICU patients have 10-20% DVT incidence with 5% mortality
20
Long-haul flights increase DVT risk by 3-fold, contributing to 1,000 deaths/year globally
21
In the US, DVT awareness campaigns reduced deaths by 20% from 2000-2010
22
Global VTE burden includes 1.2 million DVT cases yearly with 300,000 deaths
23
Surgical patients without prophylaxis have 25% DVT rate, 2% fatal
24
Trauma patients DVT incidence 50%, mortality 10-20%
25
Stroke patients bedridden have 15% DVT mortality risk
26
In China, DVT prevalence in hospitals 20-40%, deaths underreported
27
Russia estimates 100,000 VTE deaths annually from DVT
28
Canada reports 15,000 DVT/PE deaths per year
29
Italy has 30,000 VTE deaths yearly
30
Spain DVT mortality 10 per 100,000 population
Interpretation
Epidemiology Interpretation
DVT is a stealthy and relentless killer, proving that a clot in a vein is anything but a minor inconvenience as it claims hundreds of thousands of lives each year through largely preventable hospital deaths.
More related reading
04 · Category
Mortality20 stats
01
In the US, DVT/PE mortality has declined 38% from 1999-2006 due to awareness
02
Age-adjusted PE mortality rate in US was 9.5 per 100,000 in 2019
03
Untreated proximal DVT has 50% chance of fatal PE
04
30-day mortality for DVT/PE in cancer patients is 10-15%
05
Hospital mortality from PE is 15.5% in the US
06
Case-fatality rate for PE is 10-30% depending on treatment delay
07
In elderly (>80 years), DVT mortality is 20-30%
08
Massive PE mortality is 25-65% without intervention
09
Recurrent VTE mortality post-DVT is 20% at 2 years
10
In US, Black Americans have 20% higher DVT/PE mortality than Whites
11
PE mortality in US hospitals dropped from 12% to 7% 1999-2008
12
1-year mortality after DVT diagnosis is 25% in elderly
13
Submassive PE mortality 3-15% with right heart strain
14
Provoked DVT mortality 5%, unprovoked 15% at 1 year
15
In ICU, PE mortality 25-32%
16
Post-thrombectomy DVT mortality 10% in stroke patients
17
Sickle cell disease DVT/PE mortality 2x general population
18
Pregnancy PE mortality 1.1 per 100,000 deliveries US
19
Chronic thromboembolic PH mortality 30% at 5 years post-DVT
20
DVT in lower limbs causes 90% of fatal PEs
Interpretation
Mortality Interpretation
The statistics reveal a sobering truth: while increased awareness and hospital care have significantly reduced DVT and PE deaths overall, your risk of dying from a clot still cruelly depends on who you are, where it happens, and how quickly you get the right help.
05 · Category
Risk Factors21 stats
01
Obesity increases DVT death risk by 2.5-fold
02
Smoking doubles the risk of fatal DVT/PE
03
Oral contraceptive use raises DVT risk 3-6 fold in women
04
Immobility >3 days increases DVT risk by 10-fold, leading to higher deaths
05
Cancer patients have 7-fold higher VTE mortality risk
06
Previous DVT recurs in 30%, with 5% fatal PE each time
07
Heart failure triples DVT death risk
08
Varicose veins increase DVT risk by 5-fold
09
Hormone replacement therapy elevates risk 2-4 fold
10
COVID-19 infection raises DVT/PE death risk 30-fold
11
Thrombophilia (Factor V Leiden) increases fatal PE by 5-10 fold
12
Hip fracture surgery DVT risk 40-60%, mortality 1-5%
13
Surgery increases DVT risk 100-fold in first week
14
Age >60 doubles DVT mortality risk per decade
15
BMI >30 increases risk 2.7-fold for fatal VTE
16
Recent travel >4 hours triples DVT risk
17
Inherited antithrombin deficiency 20-fold risk of death
18
Lupus anticoagulant triples recurrent fatal events
19
Nephrotic syndrome DVT risk 40%, mortality high
20
PACU admission post-op DVT risk 5-10%
21
Inflammatory bowel disease 3-fold VTE death risk
Interpretation
Risk Factors Interpretation
This alarming list of multipliers suggests that the human circulatory system, while impressively resilient, is about as fond of modern lifestyles and medical interventions as a cat is of a bath.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Nathan Caldwell. (2026, February 13). Dvt Death Statistics. Gitnux. https://gitnux.org/dvt-death-statistics
MLA
Nathan Caldwell. "Dvt Death Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/dvt-death-statistics.
Chicago
Nathan Caldwell. 2026. "Dvt Death Statistics." Gitnux. https://gitnux.org/dvt-death-statistics.
Sources & references
26 datasets cited across this report · attribution is report-level